UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-40901 LUCID DIAGNOSTICS INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 82-5488042 (State or Other ...

Call Start: 16:30 January 1, 0000 5:28 PM ET Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2021 Earnings Conference Call March 28, 2022 16:30 ET CompanyParticipants Adrian Miller - Vice President of Investor Relations Dennis McGrath - Chief Financial Officer Lishan Aklog - Chairman & Chief Executive Officer Conference Call Participants Kyle Mikson - Canaccord Genuity Michael Matson - Needham & Company Ross Osborn - Cantor Fitzgerald Edward Woo - Ascendiant Capital Operator Greetings. Welcome to the Lucid Diagnost ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from______ to______ Commission File Number: 001-40901 Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 LUCID DIAGNOSTICS INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 82-5488042 (State or ...